Joyce Fingeroth to Virus Replication
This is a "connection" page, showing publications Joyce Fingeroth has written about Virus Replication.
Connection Strength
0.201
-
Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J Virol. 2013 Sep; 87(18):10126-38.
Score: 0.092
-
Dezube BJ, Zambela M, Sage DR, Wang JF, Fingeroth JD. Characterization of Kaposi sarcoma-associated herpesvirus/human herpesvirus-8 infection of human vascular endothelial cells: early events. Blood. 2002 Aug 01; 100(3):888-96.
Score: 0.043
-
Fingeroth JD. Herpesvirus infection of the liver. Infect Dis Clin North Am. 2000 Sep; 14(3):689-719.
Score: 0.038
-
Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J Virol. 2010 May; 84(9):4534-42.
Score: 0.018
-
Oram RJ, Marcellino D, Strauss D, Gustafson E, Talarico CL, Root AK, Sharma PL, Thompson K, Fingeroth JD, Crumpacker C, Herold BC. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis. 2000 Apr; 181(4):1458-61.
Score: 0.009